China Resources Pharmaceutical Group Ltd.
3320
Ранг среди акций
#4342
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Цена акции
$0.57730615
Рыночная капитализация
$3.63B
Изменение (1 день)
-3.05%
Изменение (1 год)
-6.33%
Страна
HK
Торговля China Resources Pharmaceutical Group Ltd. (3320)
Категория
Healthcare
Выручка компании China Resources Pharmaceutical Group Ltd. (3320)
Выручка на Jun 2026 TTM: $39.21B
Согласно последним финансовым отчетам China Resources Pharmaceutical Group Ltd., текущая выручка компании (TTM) составляет $39.21B. В 2023 году компания получила выручку $34.63B больше, чем выручке в 2022 году, которая составила $32.52B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки China Resources Pharmaceutical Group Ltd. с 2013 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $39.21B | 11.04% |
| 2024 | $35.32B | 1.99% |
| 2023 | $34.63B | 6.47% |
| 2022 | $32.52B | 7.07% |
| 2021 | $30.37B | 17.51% |
| 2020 | $25.85B | -1.53% |
| 2019 | $26.25B | 8.39% |
| 2018 | $24.22B | 9.67% |
| 2017 | $22.08B | 9.26% |
| 2016 | $20.21B | 6.88% |
| 2015 | $18.91B | 8.04% |
| 2014 | $17.50B | 16.05% |
| 2013 | $15.08B | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $2.54B | -93.53% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -97.88% |
US
|
|
| - | - |
IT
|
